NEW YORK (GenomeWeb) – Edico Genome said today that it raised $10 million in a Series A round of financing that it will use to commercialize its Dragen Bio-IT Processor, an application-specific integrated circuit system for next-generation sequence data analysis.

The financing round was led by Qualcomm through its venture investment group Qualcomm Ventures. The list of investors includes Axon Ventures and Greg Lucier, former Life Technologies chairman and CEO. As part of his investment, Lucier has joined Edico Genome's board of directors.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.